Literature DB >> 1484530

Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.

J Blin1, M J Vidailhet, B Pillon, B Dubois, J R Feve, Y Agid.   

Abstract

Cerebral energy metabolism was studied by positron emission tomography and [18F]fluorodeoxyglucose in five patients with clinical diagnoses of probable corticobasal degeneration. A reduction in glucose consumption was observed in most cortical and subcortical structures compared to age-matched controls. The reduction was greatest on the side of the brain contralateral to the most affected limbs, as shown by the significantly lower ratios of contralateral to homolateral metabolic rates, in the temporal and sensorimotor cortex of patients compared to controls. A distinct asymmetry between the two hemispheres could be observed in a patient who was examined twice in the course of his illness. Detection of this asymmetrical decrease in brain cortical and subcortical glucose metabolism may prove useful as additional evidence supporting clinical diagnoses of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1484530     DOI: 10.1002/mds.870070409

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Progressive frontal gait disturbance with atypical Alzheimer's disease and corticobasal degeneration.

Authors:  M N Rossor; P J Tyrrell; E K Warrington; P D Thompson; C D Marsden; P Lantos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Neuropsychological and neuroimaging correlates in corticobasal degeneration.

Authors:  E Frasson; G Moretto; A Beltramello; N Smania; M Pampanin; C Stegagno; R Tanel; N Rizzuto
Journal:  Ital J Neurol Sci       Date:  1998-10

3.  Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination.

Authors:  G K Wenning; I Litvan; J Jankovic; R Granata; C A Mangone; A McKee; W Poewe; K Jellinger; K Ray Chaudhuri; L D'Olhaberriague; R K Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

Review 4.  Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.

Authors:  D W Dickson
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

5.  Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images.

Authors:  Masato Taki; Kazunari Ishii; Tetsuya Fukuda; Yoshio Kojima; Etsuro Mori
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

Review 6.  Neuroimaging and therapeutics in movement disorders.

Authors:  Thomas Eckert; David Eidelberg
Journal:  NeuroRx       Date:  2005-04

7.  H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.

Authors:  Elisa Canu; Marina Boccardi; Roberta Ghidoni; Luisa Benussi; Cristina Testa; Michela Pievani; Matteo Bonetti; Giuliano Binetti; Giovanni B Frisoni
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

8.  A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.

Authors:  Shinsuke Fujioka; Bradley F Boeve; Joseph E Parisi; Pawel Tacik; Naoya Aoki; Audrey J Strongosky; Matt Baker; Monica Sanchez-Contreras; Owen A Ross; Rosa Rademakers; Vesna Sossi; Dennis W Dickson; A Jon Stoessl; Zbigniew K Wszolek
Journal:  Parkinsonism Relat Disord       Date:  2014-08-19       Impact factor: 4.891

9.  Neuropsychiatric features of corticobasal degeneration.

Authors:  I Litvan; J L Cummings; M Mega
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

Review 10.  Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.

Authors:  Kirk A Frey
Journal:  Semin Nucl Med       Date:  2021-01-08       Impact factor: 4.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.